PharMerica Comments on Federal Trade Commission Decision to Block Omnicare, Inc. (OCR)’s Hostile Tender Offer  
1/30/2012 6:34:05 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--PharMerica Corporation (NYSE:PMC), a national provider of institutional pharmacy and hospital pharmacy management services, today commented on the decision by the Federal Trade Commission (FTC) to sue to block Omnicare’s (NYSE: OCR) unsolicited offer to acquire PharMerica.